Summit Therapeutics Inc. — Director's Dealing 2024

Oct 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Summit Therapeutics Inc. (SMMT)
CIK: 0001599298
Period of Report: 2024-10-11

Reporting Person: Clark Kenneth A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-11	Stock Option (right to buy)	$19.95	A	200000	Acquired	2034-10-11	Common Stock (200000)	Direct

Footnotes

F1: The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025.

F2: Not applicable.